(Q35827955)

10 August 2017

1 reference

title

Anaphylaxis during surgical and interventional procedures (English)

1 reference

10 August 2017

1 reference

1 reference

1

Bernard Yu-Hor Thong

1 reference

10 August 2017

Yeow-Chan

2

1 reference

10 August 2017

1 June 2004

1 reference

Annals of Allergy, Asthma & Immunology

10 August 2017

1 reference

10 August 2017

92

1 reference

10 August 2017

6

1 reference

10 August 2017

619-628

1 reference

A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force

10 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Anaphylaxis: a review of causes and mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

The incidence and clinical features of anaphylactic reactions during anesthesia in Australia

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Epidemiology of anesthetic anaphylactoid reactions. Fourth multicenter survey (July 1994-December 1996)

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

The Epidemiology and Clinical Features of Anaphylactic Reactions in Anaesthesia

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Anaphylactic reactions during surgical and medical procedures

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Mast cell tryptase in anaesthetic anaphylactoid reactions.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Mechanisms of nonimmunological histamine and tryptase release from human cutaneous mast cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Histamine and tryptase levels in patients with acute allergic reactions: An emergency department-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Allergic reactions occurring during anaesthesia

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Allergy during anaesthesia

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

The new neuromuscular blocking agents: do they offer any advantages?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Adverse reactions to suxamethonium and other muscle relaxants under general anestesia

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Intradermal testing after anaphylactoid reaction to anaesthetic drugs: practical aspects of performance and interpretation.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Anaphylaxis during induction of general anesthesia: subsequent evaluation and management.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Rocuronium: high risk for anaphylaxis?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Intradermal compared with prick testing in the diagnosis of anaesthetic allergy.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Anaphylactic/anaphylactoid reactions to anaesthetic and associated agents. Skin prick tests in aetiological diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Cross-reactivity of metocurine, atracurium, vecuronium and fazadinium with IgE antibodies from patients unexposed to these drugs but allergic to other myoneural blocking drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Anaphylaxis to muscle relaxants: cross-sensitivity studied by radioimmunoassays compared to intradermal tests in 34 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Failure to prevent an anaphylactic reaction to a second neuromuscular blocking drug during anaesthesia.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Skin testing and the anaesthetist.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Anaphylaxis to muscle relaxant drugs: cross-reactivity and molecular basis of binding of IgE antibodies detected by radioimmunoassay.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Detection of IgE antibodies to suxamethonium after anaphylactoid reactions during anaesthesia.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Monitoring of basophil activation using CD63 and CCR3 in allergy to muscle relaxant drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Skin testing and incremental challenge in the evaluation of adverse reactions to local anesthetics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Latex allergy diagnosis: in vivo and in vitro standardization of a natural rubber latex extract

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Diagnosis of natural rubber latex allergy: multicenter latex skin testing efficacy study. Multicenter Latex Skin Testing Study Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Diagnostic performance of Food and Drug Administration-cleared serologic assays for natural rubber latex-specific IgE antibody. The multi-center latex skin testing study task force

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Receiver operating characteristics analyses of food and drug administration-cleared serological assays for natural rubber latex-specific immunoglobulin E antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Clinical and laboratory-based methods in the diagnosis of natural rubber latex allergy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Validation of a flow cytometric assay detecting in vitro basophil activation for the diagnosis of muscle relaxant allergy.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Marked improvement of the basophil activation test by detecting CD203c instead of CD63.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Desensitization of patients allergic to penicillin using orally administered beta-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Intravenous desensitization to beta-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Penicillin allergy and desensitization in serious infections during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Cephalosporin allergy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Intravenous desensitization to ceftazidime in cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Cefotaxime desensitization

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Desensitization protocols for vancomycin hypersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Diagnosis of IgE-dependent anaphylaxis to neuromuscular blocking drugs, thiopentone and opioids.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Opiate-sensitivity: clinical characteristics and the role of skin prick testing

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

The prevention of immediate generalized reactions to radiocontrast media in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Anaphylactic or anaphylactoid reactions in patients undergoing cardiac surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Association of protamine IgE and IgG antibodies with life-threatening reactions to intravenous protamine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Anaphylactic shock after aprotinin reexposure: time course of aprotinin-specific antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

[Anaphylactic reactions to aprotinin: intradermal diagnostic tests]

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Anaphylaxis to isosulfan blue

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Anaphylaxis to chlorhexidine. Case report. Implication of immunoglobulin E antibodies and identification of an allergenic determinant

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Anaphylactic reactions in anaesthetised patients - four cases of chlorhexidine allergy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Anaphylaxis caused by neostigmine.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Incidence and severity of anaphylactoid reactions to colloid volume substitutes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Anaphylactic reactions to modified fluid gelatins

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

[Anaphylactoid reactions to colloid plasma substitutes: incidence, risk factors, mechanisms. A French multicenter prospective study]

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID)

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

IgA anaphylactic transfusion reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Mastocytosis: current concepts in diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Mastocytosis. Perioperative considerations

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Anaesthetic management of systemic mastocytosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

Mastocytosis: general anesthesia with remifentanil and sevoflurane

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961427-5

7 January 2021

10.1016/S1081-1206(10)61427-5

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15237763